Source: Medical Xpress
Blood loss and the need for a blood transfusion are major concerns in joint replacement surgery, but a new use for an old drug is proving effective in reducing blood loss and transfusion rates, according to a study at Hospital for Special Surgery (HSS). The drug, tranexamic acid, or TXA, has been used for decades in heart surgery, to treat hemophilia and to stop excessive uterine bleeding.